News and Resources
Crafting a Cure for Diabetic Neuropathic Pain, Molecule by Molecule (Published by NIH)
Discover this News
Resources from the KCNQ2 Cure Alliance
Discover this News
Knopp Biosciences Receives Rare Pediatric Disease Designation for Kv7 Activator KB-3061 for Treatment of KCNQ2 Epileptic Encephalopathy
Discover this News
Discovery and characterization of KB‐3061: A potent Kv7.2/7.3 ion channel activator for the treatment of KCNQ2 epileptic encephalopathy
Discover this News
KB-3061 Is a Potent Activator of Wild Type KCNQ Channels and Restores Current to KCNQ2 Encephalopathy Variants In Vitro
Discover this News
Knopp Biosciences Presents Data Further Characterizing Its Lead Kv7.2 Activator Drug Candidate For The Treatment Of Kcnq2 Epileptic Encephalopathy At The AES 2019 Annual Meeting
Discover this News
Knopp Biosciences Receives NIH HEAL Grant to Discover and Advance Non-Opioid Treatment for Chronic Pain
Discover this News
Knopp Biosciences Receives Year 4 Renewal of NIH Blueprint Grant Award for Advancing the Kv7 Activator KB-3061 in a Rare Neonatal Epilepsy
Discover this News
Kv7.2/7.3 Activators as Precision Medicines for the Treatment of KCNQ2-EE
Discover this News
1
2
